Stock GTAB B GLYCOREX TRANSPLANTATION AB
Add to a list
To use this feature you must be a member
Log inSign up

News Glycorex Transplantation AB

Equities

GTAB B

SE0000524530

End-of-day quote NORDIC GROWTH MARKET
Other stock markets
 23:00:00 25/04/2024 BST 		5-day change 1st Jan Change
0.912 SEK -14.77% Intraday chart for Glycorex Transplantation AB -0.87% -31.17%
02-28 Glycorex Transplantation AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI
02-28 Glycorex Transplantation AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Glycorex Transplantation AB Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Glycorex Transplantation AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Glycorex Transplantation (GTAB B): Signs agreement with distributor in Romania
AQ
Glycorex Transplantation AB: Entering into an agreement with Bio-Rad Laboratories, Inc.
AQ
Glycorex Transplantation AB (publ): Interim Report January - September 2023
AQ
Glycorex Transplantation AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Glycorex Transplantation AB (publ): Interim Report January - June 2023
AQ
Glycorex Transplantation AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Glycorex Transplantation AB (publ): Interim Report January - March 2023
AQ
Glycorex Transplantation AB Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Annual Report 2022 Glycorex Transplantation AB (publ)
AQ
Published study from the US shows promising results on the use of Glycosorb® ABO to provide low-titer group O whole blood
AQ
Glycorex Transplantation AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022
CI
The first blood group incompatible kidney transplant using Glycosorb® ABO performed in South Africa
AQ
Glycorex strengthens the organization to place additional force behind the growth strategy Going 4 Growth
AQ
Glycorex Transplantation AB (GTAB B): Interim report January - September 2022
AQ
Glycorex Transplantation AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Glycorex Transplantation (GTAB B): Glycosorb[®] ABO used at the largest heart transplant center in Germany
AQ
Glycorex Transplantation AB (GTAB B): Interim report January-June 2022
AQ
Glycorex Transplantation AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GTAB B Stock
  4. News Glycorex Transplantation AB